Next Article in Journal
A Phase I Dose Escalation Study of Oxaliplatin, Cisplatin and Doxorubicin Applied as PIPAC in Patients with Peritoneal Carcinomatosis
Previous Article in Journal
The Prevalence and Characteristics of Breakthrough Cancer Pain in Patients Receiving Low Doses of Opioids for Background Pain
 
 
Article

Article Versions Notes

Cancers 2021, 13(5), 1059; https://doi.org/10.3390/cancers13051059
Action Date Notes Link
article xml file uploaded 2 March 2021 22:02 CET Original file -
article xml uploaded. 2 March 2021 22:02 CET Update https://www.mdpi.com/2072-6694/13/5/1059/xml
article pdf uploaded. 2 March 2021 22:02 CET Version of Record https://www.mdpi.com/2072-6694/13/5/1059/pdf
article supplementary file uploaded. 2 March 2021 22:02 CET - https://www.mdpi.com/2072-6694/13/5/1059#supplementary
article html file updated 2 March 2021 22:04 CET Original file -
article html file updated 25 July 2022 05:50 CEST Update https://www.mdpi.com/2072-6694/13/5/1059/html
Back to TopTop